BioStock: International specialist congress and upcoming milestones for Chordate Medical

Report this content

Chordate Medical has once again received the opportunity to present the company’s migraine treatment K.O.S at a scientific congress. This time at the International Headache Congress in Seoul, Korea, on September 14-17. In addition, the investigators in the PM007 study have submitted a manuscript for a scientific article, which CEO Anders Weilandt elaborates on.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/08/international-specialist-congress-and-upcoming-milestones-for-chordate-medical/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: International specialist congress and upcoming milestones for Chordate Medical
Tweet this